Originally published by our sister publication Pain Medicine News
By Sherree Geyer
Medications for opioid use disorder (MOUD) during the COVID-19 pandemic increased among Medicare Advantage (MA) enrollees, especially dually eligible beneficiaries and those younger than 65 years of age, a new study has found.
Researchers present a cross-sectional analysis of MA claims between Jan. 1, 2019, and March 31, 2022 (JAMA Netw Open 2023;6[5]:e2314328). Among the almost 10 million MA enrollees, almost